课题基金 / 基金详情

项目摘要

项目成果

Peter A. Lewin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The long-term objective of our proposed program is to develop a non-invasive chronic wound treatment that combines optic and acoustic modalities in a synergistic way. This theragnostic, i.e. thera(peutic) and (dia)gnostic technology, merging a non-invasive ultrasound therapy with Near Infrared (NIR) diagnostic monitoring, will allow a wound care provider to prescribe low frequency ultrasound therapy through a "Band-Aid(R)"-like wearable patch, assess the status of wound healing with digital imaging and NIR, and adjust the ultrasound parameters as necessary. The treatment considered here involves exposure of the wound to non-invasive low (20-100 kHz) frequency ultrasound energy with periodic real-time digital and near infrared (NIR) monitoring of tissue optical properties related to wound healing parameters. Thus, in vivo acquired diagnostic information provided by an optic sensor will be combined with therapy and used to direct and optimize wound healing treatment. Our ultimate goal is to develop a sterile, patient friendly patch containing an ultrasound applicator and associated electronic controls that could be directly applied by a patient to the wound. This wearable patch will allow for frequent (daily or even multiple exposures per day) application of the ultrasound therapy without a return of the patient to the clinic and will significantly increase patient compliance with the therapy. In order to accomplish this goal, we will establish the optimal ultrasound exposure parameters that will serve as the basis for the prototype "Band-Aid(R)"-like wearable ultrasound applicator. The novelty of our approach consists of using non-invasive, safe levels of low frequency ultrasound therapy with non-invasive optical diagnosis of wound healing enabled through the unique development of a low-cost wearable ultrasound applicator. This systematic approach will be validated through a study of venous ulcers in humans, providing quantitative information not available currently. Our underlying hypothesis is that low frequency ultrasound can provide an effective therapy for chronic wounds and that application of this therapy can be optimized by assessment of wound healing through NIR monitoring. Accordingly, our specific aims are: Specific Aim 1: Develop optimal exposure matrix protocol for ultrasonically assisted chronic wound healing. Identify optimal ultrasound "low" frequency (20 or 100kHz) and assess effect of total energy density on wound healing. Wound healing is assessed by NIR and wound size determination. Specific Aim 2: Based on the outcomes of Specific Aim 1, develop and test an early prototype of the "Band-Aid(R)"-like wearable ultrasound patch device based chronic wound ultrasound applicator. Specific Aim 3: Using the prototype of the ultrasound applicator developed in Specific Aim 2 identify the possible role of (inertial and stable) cavitation and mechanical stresses as possible mechanisms, and rule out thermal effects. Specific Aim 4: Validate the "Band-Aid(R)"-like wearable ultrasound patch prototype in human patients under the optimal conditions identified in Specific Aim 1. At the completion of this research, the optimum exposure matrix will be established and an early prototype of the wearable chronic wound applicator will be constructed and tested. The results of this project will also provide insights into the possible mechanisms affecting wound healing.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.ultrasmedbio.2018.05.011
发表时间: 2018-09
期刊: Ultrasound in medicine & biology
影响因子: 2.9
作者: [Bajpai A, Nadkarni S, Neidrauer M, Weingarten MS, Lewin PA, Spiller KL]
通讯作者: Spiller KL
DOI: 10.1109/tuffc.2018.2836311
发表时间: 2019-03
期刊: IEEE transactions on ultrasonics, ferroelectrics, and frequency control
影响因子: --
作者: [Ngo O, Niemann E, Gunasekaran V, Sankar P, Putterman M, Lafontant A, Nadkarni S, DiMaria-Ghalili RA, Neidrauer M, Zubkov L, Weingarten M, Margolis DJ, Lewin PA]
通讯作者: Lewin PA
Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm(2)) ultrasound exposure on carrageenan-induced arthritis in a mouse model.
在小鼠模型中,通过低频、低强度(20 kHz,100 mW/cm(2))超声照射,增强倍他米松局部给药对角叉菜胶诱导的关节炎的治疗抗炎作用。
DOI: 10.1016/j.ultrasmedbio.2015.04.009
发表时间: 2015
期刊: Ultrasound in medicine & biology
影响因子: 2.9
作者: [Cohen,Gadi, Natsheh,Hiba, Sunny,Youhan, Bawiec,ChristopherR, Touitou,Elka, Lerman,MelissaA, Lazarovici,Philip, Lewin,PeterA]
通讯作者: Lewin,PeterA
DOI: 10.1016/j.ultras.2012.03.004
发表时间: 2012-09
期刊: ULTRASONICS
影响因子: 4.2
作者: [Sunny, Youhan, Bawiec, Christopher R., Nguyen, An T., Samuels, Joshua A., Weingarten, Michael S., Zubkov, Leonid A., Lewin, Peter A.]
通讯作者: Lewin, Peter A.
Enhanced ultrasound treatment of chronic wounds with monitoring of healing and quality of life outcomes
  • 批准号:
    9473400
  • 项目类别:
  • 资助金额:
    $2.6万
  • 财政年份:
    2016
  • 负责人:
    Peter A. Lewin
  • 依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
  • 批准号:
    8274743
  • 项目类别:
  • 资助金额:
    $37.18万
  • 财政年份:
    2010
  • 负责人:
    Peter A. Lewin
  • 依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
  • 批准号:
    7886050
  • 项目类别:
  • 资助金额:
    $46.88万
  • 财政年份:
    2010
  • 负责人:
    Peter A. Lewin
  • 依托单位:
Acousto-optic Theragnostic Approach for Chronic Wound Management
  • 批准号:
    8062002
  • 项目类别:
  • 资助金额:
    $47.83万
  • 财政年份:
    2010
  • 负责人:
    Peter A. Lewin
  • 依托单位:
海外基金